Edition:
United Kingdom

Claris Lifesciences Ltd (CLAI.BO)

CLAI.BO on Bombay Stock Exchange

393.35INR
23 Feb 2018
Change (% chg)

Rs0.15 (+0.04%)
Prev Close
Rs393.20
Open
Rs393.00
Day's High
Rs393.90
Day's Low
Rs392.50
Volume
81,965
Avg. Vol
131,663
52-wk High
Rs425.70
52-wk Low
Rs308.00

Select another date:

Tue, Feb 6 2018

BRIEF-India's Claris Lifesciences Posts Dec-Qtr Consol Loss

* DEC QUARTER CONSOL LOSS 3.17 BILLION RUPEES VERSUS PROFIT 185.7 MILLION RUPEES YEAR AGO

BRIEF-Claris Lifesciences Gets Shareholders' Nod For Voluntary Delisting Of Shares From BSE

* GETS SHAREHOLDERS' NOD FOR VOLUNTARY DELISTING OF SHARES OF CO FROM BSE LTD Source text - http://bit.ly/2BnJKzv Further company coverage:

BRIEF-Claris Lifesciences Seeks Shareholders' Nod For Voluntary Delisting Of Shares From BSE

* SEEKS SHAREHOLDERS' NOD FOR VOLUNTARY DELISTING OF SHARES FROM BSE Source text: http://bit.ly/2pc6Kkm Further company coverage:

BRIEF-Claris Lifesciences Considers Voluntary Delisting Of Shares

* SAYS CONSIDERED VOLUNTARY DELISTING OF SHARES OF CO FROM BSE LTD

BRIEF-India's Claris Lifesciences Sept-qtr consol profit surges

* Sept quarter consol profit 18.40 billion rupees versus profit of 323.9 million rupees last year

BRIEF-RBI hikes foreign investment limit in Claris Lifesciences to 49 pct

* Investment limit in Claris Lifesciences Ltd by FII/FPI raised to 49 percent and increase in NRI limit from 10 to 24 per cent Source text: http://bit.ly/2goNzjF Further company coverage:

BRIEF-Claris Lifesciences completes stake sale in JV to Otsuka

* Completes sale of its stake in JV to Otsuka Pharmaceutical India Source text: (http://bit.ly/2xh4cE9) Further company coverage:

BRIEF-Claris Lifesciences gets shareholders' nod to raise FII/FPI shareholding limits in co

* Gets shareholders' nod to raise FII/FPI shareholding limits in co Source text: http://bit.ly/2hhdhD2 Further company coverage:

Select another date: